Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Paul H. Graham Image

      Paul H. Graham, M.D., M.S.

      Department of Surgical Oncology, Division of Surgery

      About Dr. Graham

      Dr. Graham graduated from The University of Texas Medical School at Houston and completed his General Surgery residency at The University of Alabama at Birmingham.  He then completed an Endocrine Surgery fellowship at Brigham and Women's Hospital in Boston.  Dr. Graham is board certified by the American Board of Surgery.  He is a member of the American College of Surgeons and the American Association of Endocrine Surgeons.  Dr. Graham holds an academic appointment as an Assistant Professor in the Department of Surgical Oncology at MD Anderson Cancer Center.  His interests include the management of both benign and malignant thyroid, parathyroid, adrenal, and neuroendocrine diseases as well as the use of minimally-invasive techniques in the surgical management of endocrine disorders.  Additional Languages spoken: Spanish.

      Read More

      Meet Paul Graham, M.D.

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2007University of Texas Medical School, Houston, Texas, US, Medical Doctor
      2002Texas A&M University, College Station, Texas, US, Biology, BS
      2025University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, US, Clinical Research, Master of Science

      Postgraduate Training

      2022-2025Clinical Research Curriculum, Masters, University of Texas McGovern School of Medicine Clinical Research, Houston
      2012-2013Surgery Fellowship, Endocrine Surgery, Brigham and Women's Hospital, Boston, Massachusetts
      2008-2012Clinical Residency, General Surgery, University of Alabama, Birmingham, Alabama
      2007-2008Clinical Internship, General Surgery, University of Alabama, Birmingham, Alabama

      Licenses & Certifications

      2017DEA
      2013Texas Medical License
      2013Massachusetts
      2013ATLS
      2013American Board of Surgery
      2012ACS Basic Ultrasound
      2012ACS Thyroid and Parathyroid Ultrasound Course
      2011Fundamentals of Laparoscopic Surgery
      2008Alabama Medical License

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020

      Instructor, Harvard Medical School, Boston, MA, 2012 - 2013

      Administrative Appointments/Responsibilities

      Fellowship Program Director, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

      Associate Program Director, Surgical Endocrinology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2020

      Other Professional Positions

      DOS Fellow’s Clinical Trials Course Program Co-Director, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2025

      DOS Fellow’s Clinical Trials Course Associate Director, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - 2021

      EPIC One Connect Superuser, MD Anderson Cancer Center, The Woodlands, TX, 2016 - Present

      Extramural Institutional Committee Activities

      Committee, Division of Education and Training Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2025

      Review Committee, MD Anderson Cancer Center Scientific Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2024

      Chair, Department of Surgical Oncology Chair Advisory Committee, The University of Texas MD Anderson Cancer Center, 2020

      Senate, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Member, DoS Cancer Network Operations Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Member, The Woodlands HAL Donor Fund Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Editorial Activities

      Ad hoc reviewer, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Honors & Awards

      2023MD Anderson Top Performer
      2022MD Anderson Top Performer
      2020MD Anderson Top Performer
      2019 - 2021Texas Rising Stars, Super Doctors
      2019MD Anderson Top Performer
      2010 - 2011Humanitarian Award, UAB- Department of Surgery
      2006Alpha Omega Alpha
      2005Outstanding Academic Achievement in Pathology, UT Houston

      Professional Memberships

      NANETS

      2025 - Present

      CGSO Entrustable Professional Activities working group

      2024 - Present

      American College of Surgeons

      2016

      Society of Surgical Oncology

      2014 - Present

      American Associate of Endocrine Surgeons

      2013

      American Association of Clinical Endocrinologists

      2013

      Harris County Medical Society

      2008 - Present

      Texas Medical Association

      2008 - Present

      Alpha Omega Alpha Honor Society

      2006

      Selected Presentations & Talks

      Local Presentations

      1. 2026. AAES Endocrine Surgery University Interesting Case Webinar. Houston, Texas, US.
      2. 2025. NETCast podcast: Patient Advocacy. Austin, Texas, US.
      3. 2025. National Adrenal Disease Foundation Adrenal Disease Awareness Webinar. Houston, Texas, US.
      4. 2025. AAES Endocrine Surgery University Interesting Case Webinar Faculty oversight – Case of MEN1. Houston, Texas, US.
      5. 2024. AAES Endocrine Surgery University Interesting Case Webinar Faculty presentation – Case of MEN2 and metastatic pheochromocytoma. Houston, Texas, US.
      6. 2023. AAES Endocrine Surgery University Interesting Case Webinar. Houston, Texas, US.
      7. 2022. Adrenocortical Carcinoma. Houston, Texas, US.
      8. 2022. AAES Endocrine Surgery University Interesting Case Webinar. Houston, Texas, US.
      9. 2021. MD Anderson Endocrine Surgery Interesting Case Videoconference/ AAES Endocrine Surgery University. Houston, Texas, US.
      10. 2019. MD Anderson Cancer Center – Preceptorship for Progenics Pharmaceuticals, Surgical Treatment of Pheochromoctyoma/Paraganglioma. Houston, Texas, US.
      11. 2018. MD Anderson Endocrine Surgery Interesting Case Videoconference. Houston, Texas, US.
      12. 2018. MD Anderson Cancer Center – Preceptorship for Eisai Pharmaceuticals, Primary Surgical Management of Well-differentiated Thyroid Cancer. Conference. MD Anderson Cancer Center. Houston, TX, US.
      13. 2018. MD Anderson Cancer Center – Preceptorship for Progenics Pharmaceuticals, Surgical Treatment of Pheochromoctyoma/Paraganglioma Patients. Conference. MD Anderson Cancer Center. Houston, TX, US.
      14. 2017. MD Anderson Endocrine Surgery Interesting Case Videoconference. Conference. MD Anderson Cancer Center. Houston, TX, US.
      15. 2017. MD Anderson Endocrine Surgery Interesting Case Videoconference. Conference. MD Anderson Cancer Center. Houston, TX, US.
      16. 2016. MD Anderson Endocrine Surgery Interesting Case Videoconference. Conference. MD Anderson Cancer Center. Houston, TX, US.
      17. 2015. MD Anderson Endocrine Surgery Interesting Case Videoconference. Conference. MD Anderson Cancer Center. Houston, TX, US.
      18. 2015. MD Anderson Endocrine Surgery Interesting Case Videoconference. Conference. MD Anderson Cancer Center. Houston, TX, US.
      19. 2014. MD Anderson Endocrine Surgery Interesting Case Videoconference. Conference. MD Anderson Cancer Center. Houston, TX, US.

      Regional Presentations

      1. 2023. MD Anderson Cancer Center Division of Surgery Fellows Clinical Trials Course. Alternative Trial Designs. Houston, Texas, US.
      2. 2022. MD Anderson Cancer Center Division of Surgery Fellows Clinical Trials Course. Alternative Trial Designs. Houston, Texas, US.
      3. 2022. Multidisciplinary Advances in Adrenocortical Carcinoma Management. Houston, Texas, US.
      4. 2022. Disease-site Educational Series, Department of Surgical Oncology Research Committee, Surgical Endocrinology Update. Houston, Texas, US.
      5. 2022. Molecular Markers and Thyroid Surgery. Austin, US.
      6. 2021. 2021 Division of Surgery Clinical Trials Course, Alternative Trial Designs. Houston, Texas, US.
      7. 2017. Surgical Considerations with Medullary Thyroid Cancer. Conference. MD Anderson Cancer Center, US.
      8. 2017. Surgical Management of Parathyroid Neoplasms. Conference. MD Anderson Cancer Center, US.
      9. 2015. 6th Current Concepts in the Management of Thyroid and Parathyroid Neoplasms Conference. Conference. MD Anderson Cancer Center, Surgical Oncology, Houston, US.
      10. 2014. Thyroid Nodules and the Risk of Thyroid Cancer. Conference. Conroe United Methodist Church, US.
      11. 2014. Preoperative Vocal Cord Assessment by Ultrasound. Conference. MD Anderson Cancer Center. Houston, US.

      National Presentations

      1. 2024. Virtual Tumor Board: MEN 2, US.
      2. 2023. Why and When Can Adrenal Metastasectomy Be Appropriate From a Surgeon Perspective. Boston, Massachusetts, US.
      3. 2021. Pheo/Para Alliance Pheo Awareness Week Webinar. OnlineOnly, US.
      4. 2019. ME209 Medullary Thyroid Cancer: What You Need to Know. Invited. ME209 Medullary Thyroid Cancer: What You Need to Know. San Francisco, CA, US.
      5. 2019. AAES Thyroid Cancer Awareness National Webinar. Invited. AAES Thyroid Cancer Awareness National Webinar, US.
      6. 2019. Pheochromocytomas and Paragangliomas: Treating the Uncommon. Invited. University of Alabama Birmingham, Department of Endocrinology Grand Rounds. Birmingham, AL, US.
      7. 2019. Adrenal Masses: Management of Common and Rare Disease. Invited. McGovern Medical School at UT Health, Department of Surgery Grand Rounds, TX, US.
      8. 2017. Reoperative Cortical-sparing Adrenalectomy via Retroperitoneoscopic Approach. Invited. ACS Clinical Congress. San Diego, CA, US.
      9. 2016. Advanced Course on Surgical Oncology for The America's 6/29/16-7/1/2016. Invited. Lymph Node Management in Differentiated Thyroid Carcinoma, US.

      International Presentations

      1. 2022. Differentiated Thyroid Cancer, US.
      2. 2022. IoPTH Assay and Primary Hyperparathyroidism Cure. Merida, PH.
      3. 2022. Endocrine Surgery Training in the US. Merida, PH.
      4. 2019. Society of Surgical Oncology Fellows Video-conference. Invited. Society of Surgical Oncology Fellows Video-conference, US.
      5. 2017. Laparoscopic versus Open Adrenalectomy in Patients with Suspected Adrenocortical Carcinoma. Invited. 6th International Adrenal Cancer Symposium. Sao Paulo, BR.
      6. 2013. Is Total Thyroidectomy Appropriate Surgery for Follicular Variant of Papillary Throid Cancer. Invited. American Association of Endocrine Surgeons Annual Meeting. Chicago, US.
      7. Advances in Medullary Thyroid Cancer. Merida, PH.

      Formal Peers

      1. 2019. Adrenal Masses: Management of Common and Rare Disease. Invited. Houston, TX, US.
      2. 2018. Endocrine Surgery Symposium. Invited, US.
      3. 2017. Endocrine Surgery Symposium. Invited, US.
      4. 2015. Endocrine Surgery Symposium. Invited, US.
      5. 2014. Endocrine Surgery Symposium. Invited, US.
      6. 2012. History of Adrenal Surgery. Invited. Birmingham, AL, US.
      Read More
      Less

      Grant & Contract Support

      Title:Paradifference Foundation
      Funding Source:University of Texas Health Science Center at San Antonio
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Hawes EE, Banuchi VE, Maniakas A, Wang JR, Graham PH, Diersing JD, Busaidy NL, Cabanillas ME, Dadu R, Hamidi S, Iyer P, Waguespack SG, Ahmed S, Alizada S, Belcastro A, Alsharif R, Hu MI, Zafereo ME. Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques. Head Neck 48(2):E20-E24, 2026. e-Pub 2026. PMID: 40747656.
      2. Shariq OA, Kensing B, Landry JP, Tzeng CD, Habra MA, Campbell MT, Fisher SB, Perrier ND, Lee JE, Graham PH. Surgical management of metastatic adrenocortical carcinoma: Is there a role for multivisceral resection?. Surgery 189:109696, 2026. e-Pub 2026. PMID: 41006153.
      3. Kim LT, Jaiswal K, Fahy B. Development of Entrustable Professional Activities for Complex General Surgical Oncology. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41193824.
      4. Zmijewski P, Kasmirski JA, Balachandra S, McLeod C, Akhund R, Allahwasaya A, Lafrinere T, Fazendin JM, Carty SE, Graham PH, Hughes DT, Lyden M, Miller BS, Finnerty BM, Yip L, Lindeman B. Learner and Teacher Entrustability Concordance in Endocrine Surgery Entrustable Professional Activities. World J Surg 49(11):3136-3141, 2025. e-Pub 2025. PMID: 41062291.
      5. Wang X, Calucho M, Estrada-Zuniga CM, Noureen M, Gonzalez-Cantu H, Mossuto S, Levi JN, Landry B, Guo Q, Rutherford KA, Cheng ZM, Sannajust A, Raghunathan S, Balaji S, da Conceicao VN, Norris S, Munawar SY, Nguyen HT, De Rosa J, Tomlinson G, Wu JX, Yeh MW, Livhits MJ, Vaidya A, Powers J, Lechan R, Tischler A, Zhang M, Graham P, Jimenez C, Peitzsch M, Bechmann N, Eisenhofer G, Ding Y, Kitano M, Soragni A, Dahia PLM. Patient-derived organoids reveal hypoxia-driven plasticity and therapeutic vulnerabilities in pheochromocytomas and paragangliomas. bioRxiv, 2025. e-Pub 2025. PMID: 40894599.
      6. Zmijewski, P, McLeod, MC, Akhund, R, Allahwasaya, A, Lafrinere, T, Fazendin, JM, Carty, SE, Graham, PH, Hughes, DT, Lyden, ML, Miller, BS, Finnerty, B, McManus, C, Yip, L, Lindeman, B. Entrustable Professional Activities in endocrine surgery. Surgery (United States) 177, 2025. e-Pub 2025. PMID: 39505596.
      7. Szabo Yamashita T, Tame-Elorduy A, Skefos CM, Varghese JM, Habra MA, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Jimenez C, Perrier ND. SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior?. Ann Surg Oncol 31(13):9007-9013, 2024. e-Pub 2024. PMID: 39382746.
      8. Feldman HA, Busaidy NL, Tame-Elorduy A, Silva AK, Halfteck G, Merriman K, Waguespack SG, Graham PH, Williams MD, Perrier ND. Clinical course of atypical parathyroid neoplasm with soft tissue extension. J Surg Oncol 130(5):1092-1096, 2024. e-Pub 2024. PMID: 39155668.
      9. Jonasch D, Habibollahi P, Kyle Jones A, Avritscher R, Habra MA, Perrier ND, Graham PH, Huang SY. Pre-procedural and intra-procedural computerized tomography: providing a roadmap for successful adrenal venous sampling procedures. Abdom Radiol (NY) 49(7):2401-2407, 2024. e-Pub 2024. PMID: 38740580.
      10. Shirali AS, Hu MI, Chiang YJ, Graham PH, Fisher SB, Sosa JA, Perrier N, Brown S, Holla VR, Dadu R, Busaidy N, Sherman SI, Cabanillas M, Waguespack SG, Zafereo ME, Grubbs EG. Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness. J Endocr Soc 8(6):bvae048, 2024. e-Pub 2024. PMID: 38660141.
      11. Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo M. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck 46(2):328-335, 2024. e-Pub 2024. PMID: 38009416.
      12. Clemente-Gutierrez U, Pieterman CRC, Lui MS, Yamashita TS, Tame-Elorduy A, Huang BL, Shirali AS, Erstad DJ, Lee JE, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Ng CS, Perrier N. Beyond the three P's: adrenal involvement in MEN1. Endocr Relat Cancer 31(2), 2024. e-Pub 2024. PMID: 38108666.
      13. Szabo Yamashita T, Shirali AS, Meas S, Sarli V, Clemente-Gutierrez UE, Chiang YJ, Silva-Figueroa A, Vodopivec DM, Williams M, Fisher SB, Graham PH, Grubbs EG, Lucci A, Busaidy N, Perrier ND. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?. Surgery 175(1):193-198, 2024. e-Pub 2024. PMID: 37993289.
      14. Sada A, Foster TR, Al-Ward R, Sawani S, Charchar H, Pishdad R, Ben-Shlomo A, Dy BM, Lyden ML, Bergsland E, Jasim S, Raj N, Shank JB, Hamidi O, Hamrahian AH, Chambo JL, Srougi V, Fragoso MC, Graham PH, Habra MA, Bancos I, McKenzie TJ. The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study. Surgery 175(1):80-89, 2024. e-Pub 2024. PMID: 37945477.
      15. Balderrama-Brondani V, Griffin AM, Owen TJ, Merriman KW, Chahla BB, Varghese J, Jimenez C, Waguespack SG, Graham PH, Perrier ND, Fisher SB, Karam JA, Shah AY, Campbell M, Hassan MM, Habra MA. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry. Endocr Pract 30(1):25-30, 2024. e-Pub 2024. PMID: 37858722.
      16. Jimenez C, Ma J, Roman Gonzalez A, Varghese J, Zhang M, Perrier N, Habra MA, Graham P, Waguespack SG. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab 108(5):1132-1142, 2023. e-Pub 2023. PMID: 36433823.
      17. Lui MS, Clemente-Gutierrez U, Vodopivec DM, Chang SL, Shirali AS, Huang BL, Chiang YJ, Fisher SB, Grubbs EG, Guise TA, Graham PH, Perrier ND. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels. World J Surg 47(2):363-370, 2023. e-Pub 2023. PMID: 36195677.
      18. Shirali AS, Clemente-Gutierrez U, Huang BL, Lui MS, Chiang YJ, Jimenez C, Fisher SB, Graham PH, Lee JE, Grubbs EG, Perrier ND. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate?. Surgery 173(1):26-34, 2023. e-Pub 2023. PMID: 36229248.
      19. Shirali AS, Graham PH. ASO Author Reflections: The Impact of Oncocytic Histology on Survival in Adrenocortical Carcinoma. Ann Surg Oncol 29(9):5564-5565, 2022. e-Pub 2022. PMID: 35536522.
      20. Shirali AS, Zagzag J, Chiang YJ, Huang H, Zhang M, Habra MA, Grubbs EG, Fisher SB, Perrier ND, Lee JE, Graham PH. Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas. Ann Surg Oncol 29(9):5555-5563, 2022. e-Pub 2022. PMID: 35499784.
      21. Sandarenu P, Millar EKA, Song Y, Browne L, Beretov J, Lynch J, Graham PH, Jonnagaddala J, Hawkins N, Huang J, Meijering E. Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images. Sci Rep 12(1):14527, 2022. e-Pub 2022. PMID: 36008541.
      22. Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, Habra MA, Halperin DM, Fisher SB, Graham PH, Perrier ND. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery 172(2):559-566, 2022. e-Pub 2022. PMID: 35437162.
      23. DiPeri, TP, Newhook, TE, Day, RW, Chiang, YJ, Dewhurst, WL, Arvide, EM, Bruno, M, Scally, CP, Roland, CL, Katz, MH, Vauthey, JN, Chang, GJ, Badgwell, BD, Perrier, ND, Grubbs, EG, Lee, JE, Tzeng, CD, Bednarski, BK, Chen, IB, Comeaux, RJ, Cox, DM, Feig, BW, Fisher, SB, Fournier, KF, Ghebremichael, SJ, Gibson, H, Gourmelon, NC, Graham, PH, Hancher-Hodges, S, Hunt, KK, Ikoma, N, Ivey MPAS, SL, Keung, EZ, Ledet, CR, Limmer, AR, Mansfield, PF, Mayon, L, Messick, C, Popat, KU, Rajkot MPAS, NF, Rodriguez-Bigas, MA, Santos, DA, Skibber, JM, Speer, BB, Soliz, J, Tillman, MM, Torres, KE, Van Meter, A, Williams, UU, You, YN. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surgery Open Science 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
      24. Landry JP, Pieterman CRC, Clemente-Gutierrez U, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study. Surgery 171(5):1240-1246, 2022. e-Pub 2022. PMID: 34952716.
      25. Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab 107(5):1239-1246, 2022. e-Pub 2022. PMID: 35092681.
      26. Srougi V, Bancos I, Daher M, Lee JE, Graham PH, Karam JA, Henriquez A, Mckenzie TJ, Sada A, Bourdeau I, Poirier J, Vaidya A, Abbondanza T, Kiernan CM, Rao SN, Hamidi O, Sachithanandan N, Hoff AO, Chambo JL, Almeida MQ, Habra MA, Fragoso MCBV. Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. J Clin Endocrinol Metab 107(4):964-971, 2022. e-Pub 2022. PMID: 34850915.
      27. Shirali AS, Wu SY, Chiang YJ, Graham PH, Grubbs EG, Lee JE, Perrier ND, Fisher SB. Recurrence after successful parathyroidectomy-Who should we worry about?. Surgery 171(1):40-46, 2022. e-Pub 2022. PMID: 34340820.
      28. Pieterman CRC, Hyde SM, Wu SY, Landry JP, Chiang YJ, Christakis I, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery 169(1):175-184, 2021. e-Pub 2021. PMID: 32703679.
      29. Pieterman CRC, Hyde SM, Wu SY, Landry JP, Chiang YJ, Christakis I, Grubbs EG, Fisher SB, Graham PH, Waguespack SG, Perrier ND. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery 169(1):175-184, 2021. e-Pub 2021. PMID: 32703679.
      30. Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
      31. Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
      32. Zafereo M, McIver B, Vargas-Salas S, Domínguez JM, Steward DL, Holsinger FC, Kandil E, Williams M, Cruz F, Loyola S, Solar A, Roa JC, León A, Droppelman N, Lobos M, Arias T, Kong CS, Busaidy N, Grubbs EG, Graham P, Stewart J, Tang A, Wang J, Orloff L, Henríquez M, Lagos M, Osorio M, Schachter D, Franco C, Medina F, Wohllk N, Diaz RE, Veliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Traipe E, Marín L, Miranda G, Bruce E, Bracamonte M, Mena N, González HE. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials. Thyroid 30(5):704-712, 2020. e-Pub 2020. PMID: 31910118.
      33. Habra MA, Sukkari MA, Hasan A, Albousen Y, Elsheshtawi MA, Jimenez C, Campbell M, Karam JA, Graham PH, Hatia RI, Phan AT, Varghese J, Hassan MM. Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study. Int J Cancer 146(7):1836-1840, 2020. e-Pub 2020. PMID: 31241762.
      34. Fisher SB, Habra MA, Chiang YJ, Wu SY, Graham PH, Grubbs EG, Lee JE, Perrier ND. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma. World J Surg 44(2):544-551, 2020. e-Pub 2020. PMID: 31493191.
      35. Wu SY, Chiang YJ, Fisher SB, Sturgis EM, Zafereo ME, Nguyen S, Grubbs EG, Graham PH, Lee JE, Waguespack SG, Perrier ND. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center. World J Surg 44(2):442-451, 2020. e-Pub 2020. PMID: 31686157.
      36. Maxwell JE, Gule-Monroe MK, Subbiah V, Hu M, Perrier ND, Cabanillas ME, Lee JE, Graham PH, Cote GJ, Busaidy NL, Grubbs EG. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma. Surgery 167(1):80-86, 2020. e-Pub 2020. PMID: 31648931.
      37. Groeben H, Walz MK, Nottebaum BJ, Alesina PF, Greenwald A, Schumann R, Hollmann MW, Schwarte L, Behrends M, Rossel T, Groeben C, Schafer M, Lowery A, Hirata N, Yamakage M, Miller JA, Cherry TJ, Nelson A, Solorzano CC, Gigliotti B, Wang TS, Wietasch JKG, Friederich P, Sheppard B, Graham PH, Weingarten TN, Sprung J. International multicentre review of perioperative management and outcome for catecholamine-producing tumours. Br J Surg 107(2):e170-e178, 2020. e-Pub 2020. PMID: 31903598.
      38. Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol 26(11):3593-3599, 2019. e-Pub 2019. PMID: 31111352.
      39. Christakis I, Ng CS, Chen C, Yiin YH, Grubbs EG, Perrier ND, Lee JE, Graham PH. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery 165(3):637-643, 2019. e-Pub 2019. PMID: 30482519.
      40. Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli B. Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Ophthalmic Plast Reconstr Surg 35(1):50-52, 2019. e-Pub 2019. PMID: 29927883.
      41. Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EG. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery 165(1):58-63, 2019. e-Pub 2019. PMID: 30392857.
      42. Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
      43. Amit M, Boonsripitayanon M, Goepfert R, Tam S, Busaidy N, Cabanillas M, Dadu R, Varghese J, Waguespack S, Gross N, Graham PH, Williams M, Sturgis E, Zafereo M. Extrathyroid Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Annals of Surgical Oncology, 2018. e-Pub 2018.
      44. Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab 102(8):2807-2813, 2017. e-Pub 2017. PMID: 28609830.
      45. Starker LF, Christakis I, Julien JS, Schwarz K, Graham P, Grubbs EG, Lee JE, Perrier ND. Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy. Am Surg 83(6):598-604, 2017. e-Pub 2017. PMID: 28637561.
      46. Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL. Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer. J Am Coll Surg 224(6):1021-1027, 2017. e-Pub 2017. PMID: 28017809.
      47. Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. J Am Coll Surg 224(5):980-987, 2017. e-Pub 2017. PMID: 28427885.
      48. Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH, Lee JE, Hu MI, Cote GJ, Gagel R, Grubbs EG. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer 16(2):283-289, 2017. e-Pub 2017. PMID: 27864651.
      49. Christakis IA, Potylchansky E, Silva AM, Nates JP, Prieto PA, Graham PH, Grubbs EG, Lee JE, Perrier ND. Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. Surgery 160(2):377-83, 2016. e-Pub 2016. PMID: 27063343.
      50. Long KL, Graham PH, Grubbs EG, Lee JE, Perrier ND. Intraoperative use of Indocyanine Green to Confirm Perfusion of Remnant Tissue in Cortical-Sparing Retroperitoneocopic Adrenalectomy. Clin Surg 1:1111, 2016. e-Pub 2016.
      51. Morris LF, Romero Arenas MA, Cerny J, Berger JS, Borror CM, Ong M, Cayo AK, Graham PH, Grubbs EG, Lee JE, Perrier ND. Streamlining variability in hospital charges for standard thyroidectomy: Developing a strategy to decrease waste. Surgery 156(6):1441-9; discussion 1449, 2014. e-Pub 2014. PMID: 25456929.
      52. Groeben H, Nottebaum B Walz M, Alesina P, Emala C, Greenwald A, Schumann R, Hollmann M, Schwarte L, Loer S, Behrends M, Duh QY, Kluijfhout W, Rossel T, Groeben C, Stubs M, Kienbaum P, Schafer M, Lowery A, Quill D, Hirata N, Yamakage M, Miller J, Cherry T, Nelson A, Nunnally M, Soloranzo C, Kiernan C, Hodin R, Parangi S, Gigliotti B, Wang T, Evans D, Wietasch J, Meier S, Kerstens M, Schrivers ANA, Bolt J, Friederich P, Gilbert E, Sheppard B, Graham PH, Lee J, Hopf H, Bancos I, Weingarten T Young Jr W, Sprung J. Perioperative Management and Outcome for Catecholamine-Producing Tumors: An International Multicenter Review. The New England Journal of Medicine.
      53. Groeben H, Nottebaum, BJ, Emala CW, Greenwald A, Schumann R, Hollmann MW, Schwarte L, Loer SA, Behrends M, Duh QY, Rossel T, Groeben C, Stubs M, Kienbaum P, Alesina PF, Walz MK, Lowery A, Hirata N, Yamakage M, Millier J, Nelson A, Nunnally M, Solorzano CC, Parangi S, Gigliotti B, Wietasch J, Meier S, Friedrich P, Gilbert EW, Sheppard B, Graham PH, Lee JE, Hopf HB, Weingarten TN, Sprung J. An International Multicenter Study of Mortality, Morbidity and Current Perioperative Management of Surgery for Catecholamine Producing Tumors.

      Invited Articles

      1. Starker LF, Prieto PA, Liles JS, Tran Cao HS, Grubbs EG, Lee JE, Perrier ND, Graham PH. In Brief. Endocrine incidentalomas. Curr Probl Surg 53(5):212-217, 2016. e-Pub 2016. PMID: 27325541.
      2. Starker LF, Prieto PA, Liles JS, Tran Cao HS, Grubbs EG, Lee JE, Perrier ND, Graham PH. Endocrine incidentalomas. Curr Probl Surg 53(5):219-46, 2016. e-Pub 2016. PMID: 27325542.

      Review Articles

      1. Jimenez C, Xu G, Varghese J, Graham PH, Campbell MT, Lu Y. New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach. Curr Oncol Rep 24(1):89-98, 2022. e-Pub 2022. PMID: 35061191.
      2. Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S, Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A, Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM, 2014. e-Pub 2014. PMID: 25642565.

      Professional Educational Materials

      1. Graham PH. American Board of Surgery CGSO Entrustable Professional Activity writing group, Endocrine section, 2024.
      2. Graham PH. American Board of Surgery Surgical Council on Resident Education (SCORE) Surgical Endocrinology curriculum, 2023.
      3. . Complex General Surgical Oncology Board Review, 2019.
      4. . Surgical Oncology Self Assessment Program, 2015.

      Other Articles

      1. Daher, M, Varghese, J, Gruschkus, SK, Jimenez, C, Waguespack, SG, Bedrose, S, Altameemi, L, Bazerbashi, H, Naing, A, Subbiah, V, Campbell, M, Shah, AY, Zhang, M, Sheth, RA, Karam, JA, Wood, CG, Perrier, ND, Graham, PH, Lee, JE, Habra, MA Erratum to. Journal of Clinical Endocrinology and Metabolism 107(8):E3544, 2022. PMID: 35536657.
      2. Roman-Gonzalez A, et al Malignant Pheochromocytoma and Sympathetic Paraganglioma Research. OncoLog 62(8):3-5, 2017.

      Abstracts

      1. Graham PH. Oncocytic adrenal tumors: A 43 case series of this rare variant. Scientific Forum program at the American College of Surgeons Clinical Congress, 2018. e-Pub 2018.
      2. Wilks JA, Zavala AM, Zhang WH, Graham PH. Pheochromocytoma and Unablated Wolff-Parkinson-White Syndrome. 2018 American Society of Anesthesiologists, 2018. e-Pub 2018.
      3. Fisher SB, Cote G, Bui-Griffith J, Lu W, Tang X, Ha T, Williams M, Wistuba I, Waguespack S, Ludwig M, Graham PH, Perrier ND, Lee JE, Grubbs EG. Genetic Characterization of Childhood Survivors of the Chernobyl Accident with Medullary Thyroid Cancer. AAES, Durham, 2018. e-Pub 2018.
      4. Romero-Arenas M, Figueroa Silva AM, Hyde SM, Graham PH, Grubbs EG, Kuerer HM, Lee JE, Perrier ND. Evidence Does Not Support Enhanced Breast Cancer Surveillance in Patients with Multiple Endocrine Neoplasia Type 1. SSO Chicago, 2018. e-Pub 2018.
      5. Habra M, Sukkari M, Jimenez C, Campbell M, Karam J, Naing A, Graham PH, Hassan M. Tobacco Use as a Risk Factor for Adrenocortical Carcinoma: A Case-Control Study. 6th International Adrenal Cancer Symposium, 2017. e-Pub 2017.
      6. Shoultz T, Rosen PDS, Reddy S, Graham PH, Chen H, Wang TN. Thyroid resection for an Undiscovered Intrathyroidal Parathyroid Gland is Justified in Select Patients with Primary Hyperparathyroidism. IAES, Basel, Switzerland, 2017. e-Pub 2017.
      7. Kutahyalioglu M, Ibrahim E, Williams MD, Dadu R, Habra MA, Hu M, Jimenez C, Waguespack S, Ying AK, Graham PH, Busaidy NL. Malignant struma overii: a case series. AACE 26th Annual Scientific and Clinical Congress Austin, 2017. e-Pub 2017.
      8. Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz FI, Cabanillas ME, Cote G, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. 86th Annual Meeting of the ATA, Denver, Colorado, 2016. e-Pub 2016.
      9. Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs M, Gawande AA, Moore, FD, Jr, Howitt B, Strickland KC, Krane JF, Barletta JA, Cho NL. Prevalence of Synchronous Thyroid Cancer in Patients with Follicular Variant of Papillary Thyroid Cancer. NESS 2016 Annual Meeting, 2016. e-Pub 2016.
      10. Thuro BA, Cabanillas ME, Busaidy NL, Dudu R, Jimenez C, Graham PH, Esmaeli B. Thyroid-related Eye Disease in Cancer Patients. International Thyroid Eye Disease Society, London, 2016. e-Pub 2016.
      11. Silva AM, Vodopivec D, Christakis I, Schwarz K, Lyons G, Long K, Waguespack S, Busaidy N, Hu M, Graham PH, Grubbs EG, Lee JE, Perrier ND. Surgical intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease compared to those with multiple endocrine neoplasia type 1-related hyperparathyroidism. AAES meeting, 2016. e-Pub 2016.
      12. Long KL, Chen H, Grubbs EG, Perrier ND, Lee JE, Graham PH. The Whole Picture: Adequacy of Lymph Node Evaluation in Pre-referral Cervical Ultrasounds Assessment. AACE 25th Annual Scientific and Clinical Congress, Orlando, 2016. e-Pub 2016.
      13. Grubbs EG, Nives-Munoz F, Gagel RF, Hu MI, Feng L, Perrier ND, Lee JE, Graham PH, Cote GJ, Williams MD. Reevaluting the significance of multifocality in sporadic medullary thyroid carcinoma. SSO Boston, 2016. e-Pub 2016.
      14. Christakis I, Starker L, Gilbert C, Conrad C, Katz, M, Qiu W, Silva A, Fellman B, Graham PH, Grubbs E, Yao J, Lee JE, Perrier N. Multiple Endocrine Neoplasia (MEN1) Patients Need Close Monitoring and Aggressive Management. 015 Neuroendocrine Tumor Symposium, North American Neuroendocrine Tumor Society, 2015. e-Pub 2015.
      15. Starker L, St Julien J, Schwarz K, Graham PH, Grubbs E, Lee J, Perrier N. Postoperative Functional Hypoaldosteronism: From Conn's to Addison's and the pages in between. AAES, Nashville, TN, 2015. e-Pub 2015.
      16. Cayo AK, Rich TA, Cote G, Williams MD, Morris LF, Romero Arenas MA, Graham PH, Evans DB, Lee JE, Perrier N, Grubbs EG. Selective parafibromin immunostaining is an effective tool in evaluating young non-MEN1 patients with primary hyperparathyroidism for CDC73 mutations. Wiener klinische Wochenschrift(S149), 2014. e-Pub 2014.
      17. Romero Arenas MA, Lucas FA, Fowler RG, Morris RS, Rich TA, Cayo AK, Graham PH, Grubbs EG, Lee JE, Scheet PA, Zhao H, Perrier ND. Mutations revealed in whole-exome sequencing implies common tumorigenicity pathways in MEN1-related hyperparathyroidism. American Association of Endocrine Surgeons Annual Meeting. e-Pub 2014.
      18. Farhood A, Trotter C, Hu M, Cabanillas M, Jackson M, Rich T, Graham PH, Lee JE, Perrier ND, Grubbs EG. Accuracy of data collected in a hereditary cancer registry, the MEN2 experience. Academic Surgical Congress, 2014. e-Pub 2014.
      19. Graham, et al. Is Total Thyroidectomy Appropriate Surgery for Follicular Variant of Papillary Thyroid Cancer, AAES, Chicago, IL. AAES, Chicago, IL, 2013. e-Pub 2013.
      20. Graham PH, et al. Re-operative Parathyroid Surgery, A Single Institution Review. University of Alabama Birmingham Resident Research Day, 2011. e-Pub 2011.
      21. M-F D, Liang YY, Chelly B, Sutton A, Graham PH, Drake R. Lung Expression NF=kB in Prolonged Heart Failure in Rats. J FASEB 19(5):A1090, 2005. e-Pub 2005.
      22. Graham PH. Minimally invasive follicular thyroid cancer can recur and lead to disease specific mortality. ATA.
      23. Graham PH. Staging of Medullary Thyroid Carcinoma: What about MX disease?. ATA.

      Book Chapters

      1. Lee M, Waugespack SG, Graham PH, Hu MI, Zafereo ME. In: Syndromic Medullary Thyroid Carcinoma: MEN2A and MEN2B, 2019.
      2. Graham PH, Dickson PV. Minimally Invasive Adrenalectomy (Laparoscopic and Retroperitoneoscopic). In: Fisher’s Mastery of Surgery. 8th ed. 8th. Wolters Kluwer.
      3. Huang B, Graham PH. In: Adrenalectomy: Open Approach. 1st ed. McGraw Hill.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • MD Anderson The Woodlands

      • Surgical Oncology Department

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top